PatientsVille.com Logo

JAUNDICE and Augmentin

PatientsVille

JAUNDICE Symptoms and Causes

Jaundice causes your skin and the whites of your eyes to turn yellow. Too much bilirubin causes Jaundice. Bilirubin is a yellow chemical in hemoglobin, the substance that carries oxygen in your red blood cells. As red blood cells break down, your body builds new cells to replace them. The old ones are processed by the liver. If the liver cannot handle the blood cells as they break down, bilirubin builds up in the body and your skin may look yellow.

Many healthy babies have some Jaundice during the first week of life. It usually goes away. However, Jaundice can happen at any age and may be a sign of a problem. Jaundice can happen for many reasons, such as

  • Blood diseases
  • Genetic syndromes
  • Liver diseases, such as hepatitis or cirrhosis
  • Blockage of bile ducts
  • Infections
  • Medicines

Check out the latest treatments for JAUNDICE

JAUNDICE treatment research studies

Augmentin clinical trials, surveys and public health registries


Find Drug Side Effect reports



Augmentin Side Effects

Diarrhoea (341)
Pruritus (324)
Rash (236)
Pyrexia (227)
Jaundice (205)
Erythema (198)
Alanine Aminotransferase Increased (194)
Dyspnoea (186)
Urticaria (180)
Anaphylactic Shock (179)
Vomiting (173)
Aspartate Aminotransferase Increased (168)
Blood Alkaline Phosphatase Increased (164)
Nausea (152)
Abdominal Pain (145)
Hypotension (136)
Cholestasis (136)
Hepatitis Cholestatic (134)
Gamma-glutamyltransferase Increased (130)
Malaise (119)
Hypersensitivity (113)
Blood Bilirubin Increased (108)
Rash Maculo-papular (104)
Face Oedema (103)
Asthenia (98)
Hepatitis (96)
Toxic Skin Eruption (92)
Abdominal Pain Upper (89)
Anaphylactic Reaction (86)
Renal Failure Acute (79)
Chromaturia (78)
Oedema Peripheral (74)
Eosinophilia (74)
Purpura (73)
Angioedema (73)
Dizziness (71)
Anaemia (69)
Bronchospasm (69)
International Normalised Ratio Increased (69)
Thrombocytopenia (67)
Tachycardia (66)
Rash Erythematous (65)
Inflammation (63)
Oedema (63)
Fatigue (61)
Pain (54)
Dehydration (54)
Anorexia (53)
Death (53)
Blood Pressure Decreased (53)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

3rd day on augmentin and i'm getting chest pain didn't think it could be related and really bad nausea when I took it this morning. They don't list that as a side effect.

After 36 hrs fom taking Tamiflu for the flu I have slight yellowing of skin and eyes. When should I be concerned?

And it has blister now ,,,im afraid i dont know what to do,,,

Augmentin 625 ; ive been on it for 2 days,feeling sick and central chest pain [ like bad heartburn]

Augmentin 625: 2x a day I've been on it for 2 days. Experienced unexplained joint pains and swelling of my hands, feet & face. Can see flashes on my left eye on the 2nd day. Have also noticed that I always want to eat.

Buna imi poate spune si mie cineva ce contine augumentinu ca eu sunt alergica la amoxicilina

Can augmentine 625 mg twice daily for five days cause as a side effect Hyperthermia

Doctor had me take amoxicillin 500mg because of sinus infection. I toke 4x500mg for 10days. It cleared up the infection but I have had acute gout attacks for over a month. my feet/hands/wrists/knees have developed terrible pain to the point that I co

Due to elevated liver enzyme levels and an elevated ANA, my previous doctor gave me a diagnosis of autoimmune hepatitis. After reviewing my charts, my current doctor believes that it was an autoimmune response to 3 back-to-back courses of amoxicillin

Has anyone developed boday aches anda fever following only a second dose? I was perfectly fine,no fever just abronchial inflamation. feel horrible!

<strong></strong>after duoloton intake i was diagonosed with fatty liver with s.g.p.t.746u/l &amp; jaundice alongwith cystic fimbrae which i had to operate out

A friend of mine. 31yrs of age has been suffering from AIHA(Auto Immuno Hemolysis) since last 8 yrs... She had suffered 2 attacks of severe jaundice, the last one in 2008.She has undergone blood transfusions 2-3 times in last 2 yrs. Her Hb

A recent problem with a gall stone blocking the bile duct left my liver compromised. Jaundice and antibiotics left me feeling exhausted. I have a sebaceous cyst on my back which has become inflamed and in infected after I bumped against a

After consuming myonal for two days, i suffer from jaundice... my bilirubin counts wer of the roof so as my ALP, and ALT count.. hmm...

Avelox taken in early March has caused me to have severe hepatitis. ALT and AST counts are in the thousands. Jaundice went away and bilirubin is normal now. All scans were negative, but a liver biopsy showed scarring and inflamation. ALT and AST star

Decrease in energy levels, severe weakness, and then ended up with liver failure and jaundice. Was hospitalized for over two weeks and a liver biopsy done. At one point, they thought I had a tumor but in the end, it was a result o

I AM IN A FIX. I HAVE JAUNDICE . MY DOCTOR SAYS THAT I CAN FEED MY 5 MONTHS OLD BABY. BUT SHE IS DOING POTTY 5TH TIME IN A DAY TODAY . SHOULD I CONTINUE TO FEED HER ?

I am taking mexium 20 mg regularly for last 1.5 years. Recent blood test have shown high level of liver enzymes . I am a non drinker and have never had any jaundice or any immunisation of hepatitis. Nexium definately messed up my healthy liver

I took clavulin for 7 days at the beginning of Sept. On Oct. 3 I became itchy from head to toe. Bloodwork showed that my liver enzymes were all elevated.I developed jaundice . I am very tired and have no energy and have missed three weeks of work wit

Is it k to smoke when having jaundice?????????

JAUNDICE Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Implementation of a Transcutaneous Bilirubinometer
Conditions: Neonatal Jaundice;   Hyperbilirubinemia
Interventions: Device: Transcutaneous Bilirubinometer;   Other: visual assessment of neonatal Jaundice
Outcome Measures: Number of blood tests for bilirubin measurement (Before the potential start of phototherapy).;   Phototherapy duration in hours;   Number of serum bilirubin-values above the 'exchange transfusion limit';   Highest measured serum bilirubin-value;   Cost-effectiveness;   Number of patients having kernicterus
2 Recruiting Immune Function in Patients With Obstructive Jaundice
Conditions: Obstructive Jaundice;   Disease as Reason for ERCP;   Immune Dysfunction;   Immune Tolerance
Intervention:
Outcome Measures: Change in monocyte cytokine responses to endotoxin stimulation;   Change in concentration of systemic quorum sensing signaling molecules
3 Not yet recruiting The Effect of Ursodeoxycholic Acid in Liver Functional Restoration of Patients With Obstructive Jaundice
Condition: Obstructive Jaundice
Intervention: Drug: Ursodeoxycholic Acid
Outcome Measures: Liver functional restoration;   To assess that in which functional parameters of the liver, treatment with UDCA will have greater impact
4 Recruiting Treatment of Neonatal Jaundice With Filtered Sunlight Phototherapy: Safety and Efficacy in African Neonates
Condition: Jaundice, Neonatal
Interventions: Procedure: Window tinting film for filtered sunlight phototherapy;   Device: conventional phototherapy
Outcome Measures: Change in Serum Bilirubin;   Incidence of Sunburn and Dehydration;   Non-inferiority of sunlight phototherapy;   Number of participants requiring intervention such as exchange blood transfusion
5 Unknown  Randomised Trial Comparing Metal and Plastic Biliary Stents Stents for Palliating Malignant Jaundice
Condition: Biliary Obstruction
Intervention: Device: SEMS
Outcome Measures: Overall cost comparison of metal versus plastic stent in patients with limited life expectancy;   Quality of life assessment
6 Recruiting Quality of Life After BDA or Stents to Treat Biliary Obstruction in Pancreas Cancer
Conditions: Local Tumor Spread;   Advanced Cancer;   Metastasized;   Pancreatic Cancer Non-resectable;   Jaundice
Interventions: Procedure: Stent;   Procedure: Biliodigestive anastomosis
Outcome Measures: Outcome of Quality of Life.;   The incidence of surgical complications and complications, with regard to the endo-scopic stent insertion, are further aspects that shall be examined in this study.
7 Unknown  Evaluation of Immune Function in Biliary Atresia Children With Prolonged Jaundice
Condition: Biliary Atresia
Intervention:
Outcome Measure:
8 Recruiting Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers
Conditions: Periampullary Cancers Causing Obstructive Jaundice;   Pancreas Head Cancer;   Bile Duct Cancer;   Ampulla of Vater Cancer
Intervention: Procedure: biliary drainage
Outcome Measures: Incidence of infectious complications after biliary drainage;   Effect of reducing serum total bilirubin after drainage;   Peritumoral inflammatory reaction after drainage;   Fibrosis of the bile duct;   Difficulties in dissection around the tumor
9 Recruiting Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination With Phototherapy in Neonates With Hyperbilirubinemia
Conditions: Jaundice, Neonatal;   Hyperbilirubinemia, Neonatal
Interventions: Drug: stannsoporfin;   Drug: Placebo
Outcome Measures: Percent change from baseline in total serum bilirubin (TSB) (the baseline TSB is the TSB that qualifies for randomization) at 48 hours post-dose;   Percent change from baseline in TSB (the baseline TSB is the TSB that qualifies for randomization) at 6, 12, 24, and 36 hours;   Total serum bilirubin area under the curve (AUC) above the baseline TSB (0 to 48 hours post-dose).;   Peak serum bilirubin;   Incidence of rebound hyperbilirubinemia defined as an increase in TSB above the age-specific threshold for initiating PT per the AAP Guidelines (AAP) following the discontinuation of the initial PT;   Incidence of readmission to hospital for hyperbilirubinemia due to a TSB at or above the age specific threshold for PT;   Duration of clinical requirement for PT;   Incidence of adverse events (AE) and serious adverse events (SAE's);   Changes in vital sign measurements;   Results of physical exam (PE), including growth measurements;   Results of neurologic exam, including eye and hearing assessment;   Electrocardiographic (ECG) assessments;   Clinical laboratory tests including hematology, serum chemistries, liver function and renal function tests
10 Unknown  Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis
Conditions: ABO Incompatibility;   Hemolytic Disease of Newborn;   Neonatal Jaundice;   Neonatal Hyperbilirubinemia
Intervention:
Outcome Measure:
11 Recruiting Comparison of Metal and Plastic Stents for Preoperative Biliary Decompression
Conditions: Obstructive Jaundice;   Pancreatic Cancer
Interventions: Procedure: Metal stent placement in the bile duct;   Procedure: Plastic stent
Outcome Measures: Complications related to stent dysfunction;   Procedural complications
12 Recruiting Prospective Randomized Study of PTC and EUS-guided Drainage of the Bile Duct
Condition: Jaundice
Interventions: Device: biliary drainage;   Device: EUS guided biliary drainage
Outcome Measures: Morbidity rate;   efficacy;   feasibility;   biliary drainage duration;   quality of life
13 Available Compassionate Use of Stanate (TM) [Stannsoporfin]
Conditions: Neonatal Jaundice;   Hyperbilirubinemia
Intervention: Drug: Stanate (TM) [stannsoporfin, tin-mesoporphyrin]
Outcome Measure:
14 Recruiting Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
Conditions: Stroke;   Rhabdomyolysis;   Jaundice
Interventions: Drug: Lovastatin;   Other: Placebo
Outcome Measures: Increase in Liver Function Tests (LFTs);   Increase in Creatine Kinase (CK);   Score on NIH Stroke Scale;   Barthel Index Score;   Modified Rankin scores
15 Recruiting ComVi Stent Versus Uncovered Self-Expandable Metal Stent (SEMS) for Biliary SEMS Occlusion
Conditions: Biliary Tract Neoplasms;   Jaundice, Obstructive
Interventions: Device: ComVi stent;   Device: Uncovered SEMS
Outcome Measure: Time to stent occlusion
16 Unknown  Acute Viral Hepatitis and Diabetes Mellitus
Conditions: Acute Viral Hepatitis;   Diabetes Mellitus
Intervention:
Outcome Measures: Duration of icteric hepatitis.;   Development of complications;   Mortality
17 Recruiting Comparison Between Endoscopic Stenting and Cholecystojejunostomy for PreoperativeDrainage Before Pancreaticoduodenectomy
Conditions: Periampullary Cancer;   Pancreatic Cancer
Interventions: Procedure: Endoscopic stenting;   Procedure: cholecystojejunostomy
Outcome Measures: Technical success;   Successful drainage;   Procedure-related complication: was defined complications directly related to stent insertion/CJ;   Intraoperative assessment;   1. Procedure-related mortality;   2. Duration of hospital stay;   3. Postoperative complication:;   a. Wound infection;   b. Intra-abdominal abscess;   c. Postoperative haemorrhage;   d. Pancreaticojejunal leak;   e. Bile leak
18 Unknown  Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar Obstruction
Conditions: Bile Duct Neoplasm;   Obstructive Jaundice
Interventions: Procedure: parallel stent;   Device: Y-stent (BONASTENT M-Hilar)
Outcome Measure: The time taken to insert bilateral stent
19 Recruiting Trial Comparing Metal Versus Plastic Stents for Preoperative Biliary Decompression
Conditions: Obstructive Jaundice;   Pancreatic Cancer
Interventions: Procedure: Stent Dysfunction;   Procedure: Complications
Outcome Measures: Complications related to stent dysfunction;   Procedural complications
20 Unknown  Observational Study of Infants Born at 34 to 37 Weeks of Gestation Until the Age of 1 Year
Conditions: Respiratory Distress;   Hypoglycemia;   Feeding Intolerance;   Jaundice;   Hypothermia;   Developmental Delay
Intervention:
Outcome Measure: neurodevelopmental, health and growth status in late preterm infants vs. controls within the first year of life